These innovative treatments, Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and potentially other disorders. These drugs are classified as GLP-1 hormone agonists , meaning these substances to replicate the endogenous GLP-1 hormone , enhancing insulin production and lowering hunger . While Tirzepatide each one